Gilyazova, Irina,
Enikeeva, Kadriia,
Rafikova, Guzel,
Kagirova, Evelina,
Sharifyanova, Yuliya,
Asadullina, Dilara,
Pavlov, Valentin (2023) , and personalization of their treatment. The review describes the most significant advances in
epigenetics of BLCA
utilized in clinical practice as reliable indicators of the disease. In addition to genetics,
epigeneticПерспективы эпигенетической терапии плоскоклеточного рака головы и шеиProspects of
epigenetic therapy of head and neck squamous cell carcinoma
Kudriashov, Valentin,
Sufianov, Albert,
Mashkin, Andrey,
Beilerli, Aferin,
Ilyasova, Tatiana,
Liang, Yanchao,
Lyulin, Sergey,
Beylerli, Ozal (2023) by many factors,
including
epigenetic ones. Histone modifications, DNA methylation, and non-coding RNAs
, including during aging. TEs’ expression
is also regulated by
epigenetic factors (DNA methylation, histone
Пути развития иммунотерапии колоректального рака for other targets, which can be used as retroelements.
Epigenetic activation of their expression
Sufianov, Albert,
Begliarzade, Sema,
Beilerli, Aferin,
Liang, Yanchao,
Ilyasova, Tatiana,
Beylerli, Ozal (2023) an
epigenetic and genetic mechanism for the development of lung cancer. The current situation with the diagnosis